Global hyaluronic acid viscosupplementation market is estimated to generate USD 4.13 billion by 2021 according to new research report

2026-08-08 06:39:05 Health and Fitness

1053

Osteoarthritis is caused due to wearing down of the joint cartilage and underlying bone in the joints. This joint disease is quite common problem faced by the aging population around the globe. Osteoarthritis can be treated with replacement surgery or injecting hyaluronic acid injection to recover the smooth movement in the joints. Most people opt in for hyaluronic injection treatment over replacement surgery due to economic reasons and for convenience of not undergoing a surgery. These are the driving factors for Hyaluronic Acid Viscosupplementation Market.

Request for Sample Data / Brochure: http://industryarc.com/pdfdownload.php?id=5338

Hyaluronic Acid Viscosupplementation Market is growing market which is mostly controlled by the USA. The US is the leading supplier and producer of the hyaluronic injection drugs for the global osteoarthritis patients; since, they own the major market shares.
Europe is the second leading region in Hyaluronic Acid Viscosupplementation Market in terms of production of the drug for the treatment of osteoarthritis affecting various areas of the body.
APAC region is the largest consumer base with high population of elderly osteoarthritis patients (due to the presence of countries like China and India) in the global Hyaluronic Acid Viscosupplementation Market. APAC region has the highest scope for growth in this market in the medical sector during the upcoming period 2016-2021 suggests market research report by IndustryARC.

Table of contents and insights:
http://industryarc.com/Report/5338/Hyaluronic-Acid-Viscosupplementation-Market-Research-Report.html

Hyaluronic Acid Viscosupplementation Market is segmented into different categories in the IndustryARC research report by course of treatment, by anatomy and by geography.
By course of treatment: single injection and multiple injections
By anatomy: knee osteoarthritis, hip osteoarthritis, ankle osteoarthritis and shoulder osteoarthritis
By geography: America (North & South), Europe, APAC and ROW
Key manufacturers and suppliers in Hyaluronic Acid Viscosupplementation Market are:
? Sanofi (France)
? Fidia Pharma USA Inc. (U.S.)
? Ferring Pharmaceuticals Inc. (Switzerland)
? Mylan Inc. (U.S.)
? Zimmer Inc. (U.S.)
These companies supply hyaluronic injections or rooster cartilage injections in high quantity in many countries across the globe.
Hyaluronic Acid Viscosupplementation Market is increasing with the rise of osteoarthritis patients across the globe. This market is expected to grow with a steady pace during the period of 2016-2021 in medical sector in various countries, thus it is a profitable investment for upcoming years.

About Us:
IndustryARC is a research and consulting firm that publishes more than 500 reports annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare.
IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business.
We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.

For More Details Contact:
Mr. Sanjay Matthews
Sales Manager
Email: sales@industryarc.com
Contact sales: 1-614-588-8538 (Ext-101)